MNKD - MannKind Corp Qarzning balans kapitallashuviga nisbati

MannKind Corp (MNKD) grafik logotipi

GURU.Markets grafigida mavjud bo'lgan MannKind Corporation (MNKD) uchun kunlik narx harakati, bunda indikator 0.00 darajasida turibdi, diabetning inyeksiyasiz terapiyalariga bo'lgan qiziqishning ortishi bilan boshqarilmoqda. Biroq, biznesning moliyaviy barqarorligi mahsulotlarning sekin joriy etilishi va sug'urta risklari tufayli cheklangan. Geopolitik mojarolar ta'minot zanjirlarini buzish va bir qator xorijiy savdo bozorlariga kirishni yopish orqali yanada bosim o'tkazmoqda.

MNKD (Afrezza) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

MannKind Corp (MNKD) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi MannKind Corporation|MNKD - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Afrezza|MNKD - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar MannKind|MNKD - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati mannkindcorp.com|MNKD - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati MannKind Corporation|MNKD - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati MannKind Corp.|MNKD - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Afrezza|MNKD - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari MannKind
Kompaniyaning barcha koʻrsatkichlari tahlili:MNKD MannKind Corporation
MannKind Corp. asosiy tovari

Ushbu ko'rsatkich kapital tuzilmasidagi qarz mablag'larining ulushini o'lchaydi, bu esa moliyaviy barqarorlikni va biznesga ortiqcha qarz yuklamasi tushishi xavfini baholash imkonini beradi. Umumiy qarzning kitob kapitalizatsiyasiga nisbatini tahlil qilish orqali investor MannKind Corporation (MNKD) o'zining innovatsion inhalatsiya orqali dori yetkazib berish tizimlari va terapiya diversifikatsiyasi rivojlanishini to'lov qobiliyatini yo'qotish xavfisiz qanchalik samarali moliyalashtirayotganini aniqlashi mumkin.

MannKind Corporation raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati SXTC (sxtchina.com)|Eupraxia Pharmaceuticals Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati BioHarvest Sciences, Inc. BHST|Invizyne Technologies, Inc. - Balans kapitallashuviga qarzlar|ORMP: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati enterabio.com|HYFT (ipatherapeutics.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati ABVC BioPharma, Inc. (ABVC)|Qarzning balans qiymatiga nisbati CPIX|Qarzning balans kapitallashuviga nisbati QNTM|Balans kapitallashuviga qarzlar FibroGen Corporation (FGEN)|Balans kapitallashuviga qarzlar TELO|Rani Therapeutics Holdings - Sof aktivlarga qarzlar|Synergy CHC Corporation (SNYR) - Qarzning balans kapitallashuviga nisbati|RLYB - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar lexariabioscience.com|Qarzning balans qiymatiga nisbati Pulmatrix Corporation|PTHL - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA (Lyra Therapeutics)|Qarzning balans qiymatiga nisbati IBO (Impact BioMedical, Inc.)|TNFA: Qarzning balans kapitallashuviga nisbati|cbdMD Inc. - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati PainReform Ltd. (PRFX)|CYTO: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Lipella Pharmaceuticals, Inc. (LIPO)|OPTN (OptiNose Inc) - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati PIRS (Pieris)|Balans qiymatiga qarzlar PROC|Petros Pharmaceuticals (PTPI) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati qlsyy.net (QLI)|Balans kapitallashuviga qarzlar SLRN (ACELYRIN)|TFFP - Balans kapitallashuviga qarzlar